Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Formal Collaboration Agreements between the University of Oxford and the Oxford Radcliffe Hospitals NHS Trust

The University of Oxford and the Oxford Radcliffe Hospitals NHS Trust have signalled their intention to cement and strengthen their collaboration in research, teaching and patient care by agreeing terms for a formal and legally-binding relationship.

There has been a long history of joint working between the University of Oxford and the NHS hospitals in Oxford, greatly benefitting both patients and the wider community.

 

Existing collaborations include the ambitious research programmes established through the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Oxford Radcliffe Hospitals NHS Trust (ORH) and at the Biomedical Research Unit in musculoskeletal disease at the Nuffield Orthopaedic Centre NHS Trust (NOC). These set the standard in translating science and research into new and better NHS clinical care.

The University and the Oxford Radcliffe Hospitals NHS Trust have agreed to formalise their relationship by entering into a Joint Working Agreement and a Trade Mark Licence. These will provide a formal structure and governance to the relationship between the two organisations, enhancing the ability to share ideas and activities and to function as a joint venture committed to the pursuit of excellence in patient care, research and education.

The intent is to complete these agreements at the same time as the ORH’s integration with the Nuffield Orthopaedic Centre NHS Trust, which is planned to take place later in the year (subject to approval by the Secretary of State for Health).

Professor Andrew Hamilton, Vice-Chancellor of Oxford University said: “We welcome this opportunity to strengthen our relationship with the hospitals further, forming the tight links which support the best teaching of medical students, excellence in medical research and the delivery of quality healthcare.

“The University has long worked closely with the Oxford Radcliffe Hospitals. These new agreements will recognise our strong mutual interests and will see us extend the way we work together, with benefits for the care which patients receive now and research on the treatments they may receive in the future.”

Sir Jonathan Michael, Chief Executive of the Oxford Radcliffe Hospitals NHS Trust, said: “The collaboration between the Oxford Radcliffe Hospitals and the University underpins the quality of the care that is provided to patients; to the delivery of high-quality research bringing innovation from the laboratory bench to the bedside; and the delivery of high-quality education and training of doctors. The decision by the Trust Board and the University Council to enter into these formal agreements reinforces this very important relationship.”

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.